SCHEMBL1855682

SCHEMBL1855682

CCOC(=O)C(=O)N(Cc1ccccc1)Cc1ccc(N)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
LMNA P02545 4/20 0.46
HSD17B10 Q99714 2/20 0.46
POLB P06746 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
TRPM8 Q7Z2W7 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
MAOA P21397 1/20 0.44
TSHR P16473 2/20 0.43
MAPK1 P28482 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
TSPO P30536 1/20 0.43
NPC1 O15118 1/20 0.43
ALOX15 P16050 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1853180 0.86 LPAR1 (0.53) ALDH1A1SMN1; SMN2
SCHEMBL25374119 0.86 TSPO (0.51) ALDH1A1LMNAHSD17B10POLBL3MBTL1
SCHEMBL1855559 0.84 NPSR1 (0.45) ALDH1A1LMNATRPM8CYP1A2CYP3A4
SCHEMBL1856855 0.84 LMNA (0.40) ALDH1A1LMNAHSD17B10POLBCYP1A2
SCHEMBL25374455 0.83 TSPO (0.46) ALDH1A1LMNAHSD17B10POLBL3MBTL1
SCHEMBL1854059 0.81 MAPT (0.56) ALDH1A1LMNAHSD17B10POLBL3MBTL1
SCHEMBL25376807 0.80 TSPO (0.46) ALDH1A1LMNAHSD17B10POLBL3MBTL1
SCHEMBL6716986 0.80 KDM4E (0.51) ALDH1A1LMNAMAOATSHRSMN1; SMN2
SCHEMBL25375165 0.79 TSHR (0.46) ALDH1A1LMNAHSD17B10POLBL3MBTL1
SCHEMBL18068877 0.79 LMNA (0.51) ALDH1A1LMNAHSD17B10POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1470102-B1 SUBSTITUTED METHYLENE AMIDE DERIVATIVES AS MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) MERCK SERONO SA (CH) 2011-05-25 EP disclosed
US-7592477-B2 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (PTPs) LABORATOIRES SERONO SA (CH) 2009-09-22 US disclosed
US-20050124656-A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) APPLIED RESEARCH SYSTEMS ARS (NL) 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124656-A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) PTPRS, PTPA, PTPMT1 ALDH1A1 3733/4885LMNA 4700/4885HSD17B10 705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.